Skip to Content

135 (Fenofibric Acid Delayed Release 135 mg)

Pill with imprint 135 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed Release 135 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 135

Fenofibric acid delayed release 135 mg 135

Fenofibric Acid Delayed Release

Imprint
135
Strength
135 mg
Color
Blue & Yellow
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Fournier Laboratories
National Drug Code (NDC)
68382-0233

Get help with Imprint Code FAQs.

Related Images for "135"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.